CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for ABBVIE INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 8, 2026

Lobbying activity 2

Health Issues

International tax issues and pharmaceutical pricing and access issues, and patent issues.

Taxation/Internal Revenue Code

International tax issues and pharmaceutical pricing and access issues, and patent issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.